Novartis Completes $28.3 B Purchase From Nestle of Majority Interest in Alcon

September 2010
Vision Monday;9/6/2010, Vol. 24 Issue 10, p008
Trade Publication
The article reports that Switzerland-based Novartis AG has acquired Nestle SA's shares in Alcon Inc., a global leader in ophthalmology which is led by its chief executive officer (CEO) and president Kevin Buehler.


Related Articles

  • TALK OF NESTL INTEREST LIFTS L'ORAL SHARES. Groves, Ellen // WWD: Women's Wear Daily;4/7/2008, Vol. 195 Issue 74, p4 

    The article reports on the increase in shares of Nestlé after market speculation that the company could buy out L'Oreal. The speculation intensified after announcement that Nestlé will sell a 24.85 percent stake in its Alcon eye care business to health care company Novartis. According to a...

  • Novartis, Alcon, finally resolve price issue for minority shares. PEDERSEN, AMANDA // Medical Device Daily;12/16/2010, Vol. 14 Issue 243, p1 

    The article reports on the agreement reached by Novartis and Alcon in December 2010 for the acquisition by the former of the remaining 23% of Alcon shares for 168 U.S. dollars a share. The other buyout deals entered by Novartis with Nestlé in 2008 and in August 2009 are briefly cited. The...

  • Novartis becomes Alcon's majority owner. Webb, Jennifer A. // Ophthalmology Times;9/15/2010, Vol. 35 Issue 18, p1 

    The article reports on the 28.3 billion dollars acquisition of Nestle S.A.'s shares of Alcon Inc. by Novartis AG in Huenenberg, Switzerland. It states that the agreement requires the resignation of five designated members of Nestle from Alcon's board of directors. It notes that Thomas G....

  • Novartis to close deal for full ownership of Alcon.  // Chain Drug Review;4/5/2010, Vol. 32 Issue 7, p31 

    The article reports that Novartis AG will gain full ownership of Alcon Inc. in New York City after completing the agreement with Nestlé SA to acquire a 77% majority stake of Alcon and entering into an all-share direct merger for the remaining 23%.

  • Massachusetts Plan Contests Alcon Buyout. Giardina, Michael // Investment Management Weekly;1/12/2010, p3 

    The article reports on the lawsuit filed by the Massachusetts Bricklayers and Mason Trust Funds against Alcon, Novartis and Nestl�. The lawsuit covers a new-pending offer which allegedly discriminates against minority shareholders. Based on court documents filed in the New York district...

  • Binge benefits. Day, Julia // Marketing Week;7/29/1999, Vol. 22 Issue 26, p24 

    Focuses on the effort of food and pharmaceutical companies in Great Britain to produce functional foods. Nestle's launch of LC1 yogurt, yogurt-style deserts and LC1 Go milk drink; Novartis' offering of healthy products like vitamins, slimming drinks and meal replacements.

  • Novartis seeks control of Alcon. Webb, Jennifer A. // Ophthalmology Times;1/15/2010, Vol. 35 Issue 2, p1 

    The article discusses the plan of Novartis AG to seek control over Alcon Laboratories Inc. It states that the company would purchase Nestle SA's 52% share of Alcon for 28 billion dollars to assume its complete control over the company. According to Novartis General Counsel Thomas Werlen, the...

  • Strategic Acquisitions Still Getting Done. Platt, Gordon // Global Finance;May2008, Vol. 22 Issue 5, p91 

    The article reports on the acquisition of Alcon Inc. by Novartis AG for $39 billion in Switzerland. The purchase complements Novartis's Ciba Vision business and its Lucentis drug for treating macular degeneration in the elderly and Novartis will pay $11 billion to food company Nestlé for a...

  • Alcon shareholders could lose more than $2 billion.  // Optometry Times;Apr2010, Vol. 2 Issue 4, p20 

    The article reports on the 12 class-action lawsuits filed by minority shareholders of Alcon stock. The lawsuits protest Novartis' decision to pay the shareholders less than it will pay Nestlé for its Alcon shares. The plaintiffs accuse Novartis, Nestlé, and Alcon's boards of directors of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics